These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 928471)

  • 1. The application of conductivity measurements to evaluate commercial digoxin tablet formulations.
    Rubinstein MH; Wells JI
    Pharm Acta Helv; 1977; 52(5):112-5. PubMed ID: 928471
    [No Abstract]   [Full Text] [Related]  

  • 2. Unit dose analysis of digoxin in tablet formulations marketed in India.
    Bansinath M; Shukla VK; Chopra KS; Bidwai PS; Mathur VS
    Indian Heart J; 1983; 35(1):54-9. PubMed ID: 6852845
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated fluorometric procedure for unit dose analysis of digitoxin and digoxin in tablet formulations.
    Cullen LF; Packmsn DL; Papariello GJ
    J Pharm Sci; 1970 May; 59(5):697-9. PubMed ID: 5446430
    [No Abstract]   [Full Text] [Related]  

  • 4. [Content uniformity for digoxin tablet].
    Tokunaga H; Kimura T; Kawamura J
    Eisei Shikenjo Hokoku; 1974; 49(92):66-70. PubMed ID: 4477502
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with a technique of assessing digoxin tablet dissolution rate.
    Raymond K; Shotton E; Patel P
    Postgrad Med J; 1974 Nov; 50 Suppl 6():40-3. PubMed ID: 4459887
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of factors affecting dissolution of digoxin from tablets.
    Hasegawa S; Sonobe T; Kawata H; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Jul; 26(7):2098-104. PubMed ID: 688533
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of tablet dissolution by magnetic resonance electric current density imaging.
    Mikac U; Demsar A; Demsar F; Sersa I
    J Magn Reson; 2007 Mar; 185(1):103-9. PubMed ID: 17188009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Film-coated zinc sulphate tablets and the effect of humidity on tablet properties.
    Gürsoy A; Akbuğa J
    Pharmazie; 1986 Aug; 41(8):575-8. PubMed ID: 3786379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative study of a semiautomated colorimetric analysis of digoxin tablets.
    Juhl WE
    J Assoc Off Anal Chem; 1975 Jan; 58(1):70-4. PubMed ID: 1141158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution properties of different designed and formulated salbutamol tablet dosage forms.
    Ozkan Y; Savaşer A; Ozalp Y; Işimer A
    Acta Pol Pharm; 2000; 57(4):271-6. PubMed ID: 11126615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid quantitative GLC analysis of digoxin.
    Kibbe AH; Araujo OE
    J Pharm Sci; 1973 Oct; 62(10):1702-3. PubMed ID: 4356501
    [No Abstract]   [Full Text] [Related]  

  • 17. [Solvent system design for silica gel liquid chromatography of digitalis glycosides. Determination of digoxin in pharmaceutical preparation].
    Sato A; Ito Z; Noguchi M; Oka K; Ijitsu T; Hara S
    Yakugaku Zasshi; 1984 May; 104(5):454-7. PubMed ID: 6491883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inquiry about the in vitro release of methaqualone from commercial tablet formulations (author's transl)].
    Kerstenne F; Moës A
    J Pharm Belg; 1980; 35(2):150-2. PubMed ID: 7391928
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative dissolution testing of paracetamol commercial tablet dosage forms.
    Ozkan Y; Ozalp Y; Savaşer A; Ozkan SA
    Acta Pol Pharm; 2000; 57(1):33-41. PubMed ID: 10846795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.